利伐沙班用量多少？

How much rivaroxaban is needed? The recommended dosage in the instructions for rivaroxaban is: oral administration, 10 mg of rivaroxaban, once daily. If the wound has stopped bleeding, the first medication should be administered between 6 and 10 hours after surgery. Can be taken with food or alone. Rivaroxaban 15 mg or 20 mg should be taken with food.

Rivaroxaban to prevent deep vein thrombosis after hip replacement: 10 mg, once a day, treatment course for 35 days.

Rivaroxaban to prevent deep vein thrombosis after knee replacement: 10 mg, once a day, 12 days of treatment.

For the treatment of deep vein thrombosis and pulmonary embolism: The dose is 15 mg twice daily with meals for 21 days. For maintenance treatment and to reduce the risk of deep vein thrombosis and pulmonary embolism, the dose is 20 mg once daily with a meal.

For reducing the risk of stroke in non-valvular atrial fibrillation: 20 mg orally once daily with dinner. For patients who are underweight and older than 75 years old, 15 mg once a day can be used as appropriate.

When switching from warfarin to this drug, start treatment with rivaroxaban as soon as possible after stopping warfarin and the international normalized ratio (INR) falls below 3.0. In patients treated for deep vein thrombosis, and in patients with reduced risk of deep vein thrombosis and pulmonary embolism, rivaroxaban treatment should be initiated when the international normalized ratio (INR) is less than 2.5 after warfarin is discontinued.

For patients receiving other non-oral anticoagulants, when switching to this drug for non-continuous administration, such as subcutaneous injection of low-molecular-weight heparin, rivaroxaban can be taken 0 to 2 hours before other anticoagulants should be used at night; for patients receiving continuous administration, such as intravenous unfractionated heparin, rivaroxaban can be taken after stopping heparin.

No dose adjustment is required for geriatric patients over 65 years of age.

The safety and effectiveness of the drug in children have not been determined, and rivaroxaban is not recommended for use in adolescents or children under 18 years of age.